Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review
暂无分享,去创建一个
[1] J. Hardy,et al. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease , 1986, Neurobiology of Aging.
[2] W. Robison. Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors. , 1988, Advances in experimental medicine and biology.
[3] Sanford L. Palay,et al. The fine structure of the nervous system: The neurons and supporting cells , 1976 .
[4] G. V. Van Hoesen,et al. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease , 1987, Annals of neurology.
[5] A. Vaheri,et al. Laminin is induced in astrocytes of adult brain by injury. , 1984, The EMBO journal.
[6] D. Abrahamson,et al. Proteinuria and structural alterations in rat glomerular basement membranes induced by intravenously injected anti-laminin immunoglobulin G , 1982, The Journal of experimental medicine.
[7] Sandra R. Smith,et al. An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Timpl,et al. In vivo localization and pathological effects of passively transferred antibodies to type IV collagen and laminin in mice. , 1982, Clinical immunology and immunopathology.
[9] D. Price,et al. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. , 1987, Science.
[10] K M Yamada,et al. Cell surface interactions with extracellular materials. , 1983, Annual review of biochemistry.
[11] W. Pardridge,et al. Journal of Cerebral Blood Flow and Metabolism Antibodies to Blood-brain Barrier Bind Selectively to Brain Capillary Endothelial Lateral Membranes and to a 46k Protein , 2022 .
[12] R. Spiro,et al. Effect of Diabetes on the Glycosaminoglycan Component of the Human Glomerular Basement Membrane , 1982, Diabetes.
[13] G. Glenner. Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia). , 1979, Medical hypotheses.
[14] A. Negro,et al. Macromolecular organization and functional architecture of basement membranes. , 1984, Applied pathology.
[15] M. Kidd. ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY. , 1964, Brain : a journal of neurology.
[16] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[17] Thomas We,et al. Brain macrophages: questions of origin and interrelationship. , 1988 .
[18] S. Palay,et al. The Fine Structure of the Nervous System: Neurons and Their Supporting Cells , 1991 .
[19] H. Thoenen,et al. The heparin‐binding domain of laminin is responsible for its effects on neurite outgrowth and neuronal survival. , 1984, The EMBO journal.
[20] L. Autilio‐Gambetti,et al. Paired helical filaments: Do they contain neurofilament epitopes? , 1986, Neurobiology of Aging.
[21] Z. Nagy,et al. Charge-related alterations of the cerebral endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[22] E. Lillehoj,et al. Normal and abnormal aspects of proteinuria. Part I: Mechanisms, characteristics and analyses of urinary protein. Part II: Clinical considerations. , 1986, Experimental pathology.
[23] C. Cotman,et al. Senile plaques as aberrant sprout-stimulating structures , 1986, Experimental Neurology.
[24] H. Chui,et al. Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease , 1990, Neuroscience Letters.
[25] R. Kisilevsky,et al. A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[26] C. Cotman,et al. Amyloid beta protein enhances the survival of hippocampal neurons in vitro. , 1989, Science.
[27] M. Hart,et al. Differential opening of the brain endothelial barrier following neutralization of the endothelial luminal anionic charge in vitro. , 1987, Journal of neuropathology and experimental neurology.
[28] G. Cole,et al. Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein. , 1988, Science.
[29] S. Radin,et al. Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio. , 1989, Ophthalmic research.
[30] M. Graeber,et al. Identity of ED2‐positive perivascular cells in rat brain , 1989, Journal of neuroscience research.
[31] P. Davies,et al. Dementia of the Alzheimer type. , 1980, Annual review of neuroscience.
[32] H. Chui,et al. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease , 1990, Brain Research.
[33] J. Roder,et al. Neuronal proteoglycans: biosynthesis and functional interaction with neurons in vitro , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[34] J. Wegiel,et al. Ultrastructural Studies of the Cells Forming Amyloid Fibers in Classical Plaques , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[35] G. Glenner,et al. Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[36] A. Lander,et al. Purification of a factor that promotes neurite outgrowth: isolation of laminin and associated molecules , 1985, The Journal of cell biology.
[37] W. Oldendorf,et al. Blood-brain barrier: interface between internal medicine and the brain. , 1986, Annals of internal medicine.
[38] H. Stadler,et al. Identification of a heparan sulphate‐containing proteoglycan as a specific core component of cholinergic synaptic vesicles from Torpedo marmorata. , 1982, The EMBO journal.
[39] C. P. Hughes,et al. Nosologic problems in dementia , 1973, Neurology.
[40] D. Selkoe,et al. Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease , 1989, Nature.
[41] M. Esiri,et al. Cerebral amyloid angiopathy in dementia and old age. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[42] C. P. Leblond,et al. Identification of microglia in light and electron microscopy , 1969, The Journal of comparative neurology.
[43] H. Wiśniewski,et al. Evidence for Blood‐Brain Barrier Changes in Senile Dementia of the Alzheimer Type (SDAT) , 1982, Annals of the New York Academy of Sciences.
[44] G. Glenner,et al. β-PLEATED SHEET FIBRILS A COMPARISON OF NATIVE AMYLOID WITH SYNTHETIC PROTEIN FIBRILS , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[45] R. Kisilevsky. From arthritis to Alzheimer's disease: current concepts on the pathogenesis of amyloidosis. , 1987, Canadian journal of physiology and pharmacology.
[46] P. Amenta,et al. The basement membrane in pathology. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[47] B. Deurs. Observations on the blood-brain barrier in hypertensive rats, with particular reference to phagocytic pericytes , 1976 .
[48] D. Gospodarowicz,et al. Characterization of a factor that promotes neurite outgrowth: evidence linking activity to a heparan sulfate proteoglycan , 1982, The Journal of cell biology.
[49] C. Wilson,et al. Immunopathology and glomerulonephritis. , 1974, Annual review of medicine.
[50] L. Reichardt,et al. Appearance and distribution of neuronal cell surface and synaptic vesicle antigens in the developing rat superior cervical ganglion , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[51] R. Martins,et al. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. , 1985, The EMBO journal.
[52] A. Lander,et al. Laminin is associated with the "neurite outgrowth-promoting factors" found in conditioned media. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Stow,et al. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening , 1986, The Journal of experimental medicine.
[54] Bradbury Mw. The structure and function of the blood-brain barrier. , 1984 .
[55] T. Miyakawa,et al. The relationship between senile plaques and cerebral blood vessels in Alzheimer’s disease and senile dementia , 1982, Virchows Archiv. B, Cell pathology including molecular pathology.
[56] H. Kleinman,et al. Alterations in the Basement Membrane (Heparan Sulfate) Proteoglycan in Diabetic Mice , 1982, Diabetes.
[57] K. Iqbal. Biology of Alzheimer's disease through biochemistry of tangles and plaques , 1986, Neurobiology of Aging.
[58] C. C. Clark,et al. Biochemistry and metabolism of basement membranes. , 1979, International review of cytology.
[59] R. Cotran,et al. Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins , 1975, The Journal of cell biology.
[60] H. Fillit,et al. Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type. , 1987, Journal of gerontology.
[61] S. Rapoport,et al. Examination of Blood — Brain Barrier Permeability in Dementia of the Alzheimer Type with [68Ga]EDTA and Positron Emission Tomography , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[62] G. Goldstein,et al. In Vitro Studies of the Blood‐Brain Barrier Using Isolated Brain Capillaries and Cultured Endothelial Cells a , 1986, Annals of the New York Academy of Sciences.
[63] H. Kleinman,et al. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[64] D. Rifkin,et al. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture , 1989, The Journal of cell biology.
[65] J. D. Gregory,et al. Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan , 1985, The Journal of experimental medicine.
[66] G. Goldstein,et al. Recent advances in understanding brain capillary function , 1983, Annals of neurology.
[67] D. Nochlin,et al. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.
[68] P. Yates,et al. IMMUNOHISTOCHEMICAL STAINING OF SENILE PLAQUES , 1982, Neuropathology and applied neurobiology.
[69] A. Scheibel,et al. DENERVATION MICROANGIOPATHY IN SENILE DEMENTIA, ALZHEIMER TYPE , 1987, Alzheimer disease and associated disorders.
[70] D. Cogan,et al. The mural cell in perspective. , 1967, Archives of ophthalmology.
[71] C. Cotman,et al. Plasticity of hippocampal circuitry in Alzheimer's disease. , 1985, Science.
[72] W. Zeman. ALTERATIONS OF BASEMENT MEMBRANES OF CEREBRAL CAPILLARIES , 1967, Journal of Neuropathology and Experimental Neurology.